co-delivered collagenase and trastuzumab into HER2-positive BT474 tumor-bearing mice using a thermosensitive hydrogel, promoting the penetration of therapeutic antibodies into deeper tumor tissues (106, 155). This evidence concerns the gene ERBB2 and neoplasm.